Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status

Aims:  The pathogenesis of breast carcinoma in very elderly women is of interest, because oestrogen levels are likely to be extremely low during the development of the disease. In an effort to understand the pathogenesis of breast carcinoma in these women, this study was undertaken to compare the histological patterns and hormone receptor status of breast carcinomas arising in very elderly and younger women.

[1]  S. Friedman,et al.  Invasive apocrine carcinoma of the breast: A long term follow-up study of 34 cases , 1988, Breast Cancer Research and Treatment.

[2]  J. Dixon,et al.  Androgen metabolism and apocrine differentiation in human breast cancer , 2005, Breast Cancer Research and Treatment.

[3]  K. Schulz,et al.  Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells , 2004, Journal of Cancer Research and Clinical Oncology.

[4]  R. Laucirica,et al.  Estrogen receptor beta expression in invasive breast cancer. , 2001, Human pathology.

[5]  R. Elledge,et al.  Tumor characteristics and clinical outcome of elderly women with breast cancer. , 2000, Journal of the National Cancer Institute.

[6]  J. Daurès,et al.  Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause , 1998, Cancer.

[7]  F. Tavassoli,et al.  Mucinous cystadenocarcinoma of the breast. , 1998, The American journal of surgical pathology.

[8]  R. Skjaerven,et al.  Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status. , 1996, Journal of clinical pathology.

[9]  G. Bratthauer,et al.  Androgen Receptor Expression Along with Loss of bcl‐2, ER, and PR Expression in Benign and Malignant Apocrine Lesions of the Breast: Implications for Therapy , 1996 .

[10]  D. Winchester,et al.  Patterns of breast cancer care in the elderly , 1996, Cancer.

[11]  C. Longcope,et al.  Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  J. Pink,et al.  Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. , 1996, Cancer research.

[13]  F Berrino,et al.  Serum sex hormone levels after menopause and subsequent breast cancer. , 1996, Journal of the National Cancer Institute.

[14]  D. Horsfall,et al.  Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Isola.  Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors , 1993, The Journal of pathology.

[16]  V. Kuenen-Boumeester,et al.  Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer , 1992, International journal of cancer.

[17]  K. Schulz,et al.  Androgen sensitivity of the new human breast cancer cell line MFM-223. , 1991, Cancer research.

[18]  E. Milgrom,et al.  Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. , 1991, The EMBO journal.

[19]  M. Fernö,et al.  Estrogen and Progesterone Receptor Analyses in More Than 4000 Human Breast Cancer Samples: A Study with Special Reference to Age at diagnosis and stability of analyses , 1990 .

[20]  S. Toikkanen,et al.  Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long-term follow-up. , 1989, Human pathology.

[21]  N. Walford,et al.  Histiocytoid breast carcinoma: an apocrine variant of lobular carcinoma , 1989, Histopathology.

[22]  S. Thorpe.  Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance. , 1988, Acta oncologica.

[23]  S. J. Davis,et al.  Characteristics of breast cancer in women over 80 years of age. , 1985, American journal of surgery.

[24]  P. Rosen,et al.  Breast carcinoma at the extremes of age: A comparison of patients younger than 35 years and older than 75 years , 1985, Journal of surgical oncology.

[25]  V. Eusebi,et al.  Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study. , 1984, Human pathology.

[26]  D. Haagensen,et al.  Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. , 1983, The American journal of pathology.

[27]  K. Mccarty,et al.  Apocrine differentiation in human mammary carcinoma. , 1980, Cancer.

[28]  C C Spicer,et al.  Relation between urinary androgen and corticoid excretion and subsequent breast cancer. , 1971, Lancet.

[29]  A. Macara,et al.  The Care of the Elderly , 1946, Bristol medico-chirurgical journal.

[30]  W. Frable,et al.  Carcinoma of the breast. Histologic and clinical features of apocrine tumors , 1968, Cancer.

[31]  G. Beatson.  On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases , 1896, Transactions. Medico-Chirurgical Society of Edinburgh.